|
1
|
Gharwan H, Bunch KP and Annunziata CM: The
role of reproductive hormones in epithelial ovarian carcinogenesis.
Endocr Relat Cancer. 22:R339–R363. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mertens-Walker I, Baxter RC and Marsh DJ:
Gonadotropin signalling in epithelial ovarian cancer. Cancer Lett.
324:152–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Paulson RJ: Treatment of infertility and
the risk of ovarian cancer: Are the data reassuring? Fertil Steril.
105:605–606. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Burdette JE, Kurley SJ, Kilen SM, Mayo KE
and Woodruff TK: Gonadotropin-induced superovulation drives ovarian
surface epithelia proliferation in CD1 mice. Endocrinology.
147:2338–2345. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rodgers LH, Oh E, Young AN and Burdette
JE: Loss of PAX8 in high-grade serous ovarian cancer reduces cell
survival despite unique modes of action in the fallopian tube and
ovarian surface epithelium. Oncotarget. 7:32785–32795.
2016.PubMed/NCBI
|
|
6
|
Rzepka-Górska I, Chudecka-Głaz A and
Kosmowska B: FSH and LH serum/tumor fluid ratios and malignant
tumors of the ovary. Endocr Relat Cancer. 11:315–321. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Saddick SY: In vitro regulation of sheep
ovarian surface epithelium (OSE) proliferation by local ovarian
factors. Saudi J Biol Sci. 19:285–290. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mertens-Walker I, Bolitho C, Baxter RC and
Marsh DJ: Gonadotropin-induced ovarian cancer cell migration and
proliferation require extracellular signal-regulated kinase 1/2
activation regulated by calcium and protein kinase C{delta}. Endocr
Relat Cancer. 17:335–349. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hilliard TS, Modi DA and Burdette JE:
Gonadotropins activate oncogenic pathways to enhance proliferation
in normal mouse ovarian surface epithelium. Int J Mol Sci.
14:4762–4782. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tourgeman DE, Lu JJ, Boostanfar R, Amezcua
C, Felix JC and Paulson RJ: Human chorionic gonadotropin suppresses
ovarian epithelial neoplastic cell proliferation in vitro. Fertil
Steril. 78:1096–1099. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ivarsson K, Sundfeldt K, Brännström M,
Hellberg P and Janson PO: Diverse effects of FSH and LH on
proliferation of human ovarian surface epithelial cells. Hum
Reprod. 16:18–23. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim D, Lee J and Johnson AL: Vascular
endothelial growth factor and angiopoietins during hen ovarian
follicle development. Gen Comp Endocrinol. 232:25–31. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tzuman YC, Sapoznik S, Granot D, Nevo N
and Neeman M: Peritoneal adhesion and angiogenesis in ovarian
carcinoma are inversely regulated by hyaluronan: The role of
gonadotropins. Neoplasia. 12:51–60. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lau M-T, Wong AST and Leung PCK:
Gonadotropins induce tumor cell migration and invasion by
increasing cyclooxygenases expression and prostaglandin E(2)
production in human ovarian cancer cells. Endocrinology.
151:2985–2993. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Harris RE: Cyclooxygenase-2 (cox-2) and
the inflammogenesis of cancer. Subcell Biochem. 42:93–126. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Moran EM: Epidemiological and clinical
aspects of nonsteroidal anti-inflammatory drugs and cancer risks. J
Environ Pathol Toxicol Oncol. 21:193–201. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pang LY, Hurst EA and Argyle DJ:
Cyclooxygenase-2: A role in cancer stem cell survival and
repopulation of cancer cells during Therapy. Stem Cells Int.
2016:20487312016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang X, Baek SJ and Eling T: COX
inhibitors directly alter gene expression: Role in cancer
prevention? Cancer Metastasis Rev. 30:641–657. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Duffy DM: Novel contraceptive targets to
inhibit ovulation: The prostaglandin E2 pathway. Hum Reprod Update.
21:652–670. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rask K, Zhu Y, Wang W, Hedin L and
Sundfeldt K: Ovarian epithelial cancer: A role for PGE2-synthesis
and signalling in malignant transformation and progression. Mol
Cancer. 5:622006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li S, Miner K, Fannin R, Barrett Carl J
and Davis BJ: Cyclooxygenase-1 and 2 in normal and malignant human
ovarian epithelium. Gynecol Oncol. 92:622–627. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Menczer J: Cox-2 expression in ovarian
malignancies: A review of the clinical aspects. Eur J Obstet
Gynecol Reprod Biol. 146:129–132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee JY, Myung SK and Song YS: Prognostic
role of cyclooxygenase-2 in epithelial ovarian cancer: A
meta-analysis of observational studies. Gynecol Oncol. 129:613–619.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Whynott RM, Manahan P and Geisler JP:
Vascular endothelial growth factor (VEGF) and cyclooxygenase 2 (COX
2) immunostaining in ovarian cancer. Eur J Gynaecol Oncol.
37:164–166. 2016.PubMed/NCBI
|
|
25
|
Futaki N, Takahashi S, Yokoyama M, Arai I,
Higuchi S and Otomo S: NS-398, a new anti-inflammatory agent,
selectively inhibits prostaglandin G/H synthase/cyclooxygenase
(COX-2) activity in vitro. Prostaglandins. 47:55–59. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Choi JH, Wong AS, Huang HF and Leung PC:
Gonadotropins and ovarian cancer. Endocr Rev. 28:440–461. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wright JW, Toth-Fejel S, Stouffer RL and
Rodland KD: Proliferation of rhesus ovarian surface epithelial
cells in culture: lack of mitogenic response to steroid or
gonadotropic hormones. Endocrinology. 143:2198–2207. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Barczyński B, Rogala E, Nowicka A,
Nurzyńska-Flak J and Kotarski J: Pelvic pain, free fluid in pelvis,
and human chorionic gonadotropin serum elevation: Recurrence of
malignant ovarian germ-cell tumor or early pregnancy? Eur J
Gynaecol Oncol. 34:489–492. 2013.PubMed/NCBI
|
|
29
|
Guo Z, Jiang J-H, Zhang J, Yang HJ, Yang
FQ, Qi YP, Zhong YP, Su J, Yang RR, Li LQ, et al: COX-2 promotes
migration and invasion by the side population of cancer stem
cell-like hepatocellular carcinoma cells. Medicine (Baltimore).
94:e18062015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Majumder M, Landman E, Liu L, Hess D and
Lala PK: COX-2 elevates oncogenic miR-526b in breast cancer by EP4
activation. Mol Cancer Res. 13:1022–1033. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu Y, Sun H, Hu M, Zhang Y, Chen S, Tighe
S and Zhu Y: The Role of cyclooxygenase-2 in colorectal
carcinogenesis. Clin Colorectal Cancer. Oct 6–2016.(Epub ahead of
print). View Article : Google Scholar :
|
|
32
|
Hua H-K, Jin C, Yang L-J, Tao S-Q and Zhu
X-H: Expression of cyclooxygenase-2 in squamous cell carcinoma and
keratoacanthoma and its clinical significance. Cell Biochem
Biophys. 72:475–480. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Maeng H-J, Lee W-J, Jin Q-R, Chang J-E and
Shim W-S: Upregulation of COX-2 in the lung cancer promotes
overexpression of multidrug resistance protein 4 (MRP4) via
PGE2-dependent pathway. Eur J Pharm Sci. 62:189–196. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tang Y, Lv P, Sun Z, Han L and Zhou W and
Zhou W: 14-3-3β Promotes migration and invasion of human
hepatocellular carcinoma cells by modulating expression of MMP2 and
MMP9 through PI3K/Akt/NF-κB pathway. PLoS One. 11:e01460702016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bottoni P, Isgrò MA and Scatena R: The
epithelial-mesenchymal transition in cancer: A potential critical
topic for translational proteomic research. Expert Rev Proteomics.
13:115–133. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kurtova AV, Xiao J, Mo Q, Pazhanisamy S,
Krasnow R, Lerner SP, Chen F, Roh TT, Lay E, Ho PL, et al: Blocking
PGE2-induced tumour repopulation abrogates bladder cancer
chemoresistance. Nature. 517:209–213. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang G, Panigrahy D, Hwang SH, Yang J,
Mahakian LM, Wettersten HI, Liu JY, Wang Y, Ingham ES, Tam S, et
al: Dual inhibition of cyclooxygenase-2 and soluble epoxide
hydrolase synergistically suppresses primary tumor growth and
metastasis. Proc Natl Acad Sci USA. 111:11127–11132. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Majumder M, Xin X, Liu L, Tutunea-Fatan E,
Rodriguez-Torres M, Vincent K, Postovit LM, Hess D and Lala PK:
COX-2 induces breast cancer stem cells via EP4/PI3K/AKT/NOTCH/WNT
axis. Stem Cells. 34:2290–2305. 2016. View Article : Google Scholar : PubMed/NCBI
|
